Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 557/MEDI5872 in Primary Sjögren's Syndrome
NCT02334306Phase 2Completed
- Sponsor
- MedImmune
- Start
- Jun 2015
- Primary completion
- Jan 2018
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of prezalumab, sponsored by MedImmune. Started Jun 2015; status: completed.
02
Drugs
prezalumab
Beyond the preview
Go deeper on NCT02334306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334306.